Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of cadherin-11 antagonists to treat metabolic disorders and/or increase insulin sensitivity

Use of cadherin-11 antagonists to treat metabolic disorders and/or increase insulin sensitivity

US Patent 11097005 · Granted Aug 24, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods relating to T peripheral helper cells in autoantibody-a2022
Methods and compositions for treatment of metabolic disorders2018
Detection and treatment of non-dermal fibrosis2014
Apolipoprotein E as an adjuvant for lipid antigens2009
Methods and compositions for treatment of inflammatory disease using cadherin-112009
Methods and compositions for treatment of inflammatory disease using cadherin-112009
Presentation of hydrophobic antigens to T-cells by CD1 molecules2006
Methods and compositions for modulating heterotypic E-cadherin interactions with2006
Methods and compositions for treatment of inflammatory disease using cadherin-112005
Methods and compositions for treatment of inflammatory disease using cadherin-112004
Pharmaceutical compositions containing triazolones and methods of treating neuro2002
Method of treating ulcerative colitis or crohn's disease by administering an ant2002